Related party transactions - Additional information (Details) € in Thousands |
6 Months Ended | ||
|---|---|---|---|
|
Apr. 23, 2025
EUR (€)
|
Jun. 30, 2026
EUR (€)
licensing_agreement
contract
|
Jun. 30, 2025
EUR (€)
|
|
| Disclosure of transactions between related parties [Line Items] | |||
| Provision for expenses with related parties | € 81 | ||
| Provision for attendance fees | € 258 | ||
| Issue of equity | € 0 | € 14,932 | |
| Novo Nordisk A/S | |||
| Disclosure of transactions between related parties [Line Items] | |||
| Number of licensing agreements | licensing_agreement | 3 | ||
| Amounts payable, related party transactions | € 0 | ||
| Sanofi-Aventis | |||
| Disclosure of transactions between related parties [Line Items] | |||
| Amounts payable, related party transactions | € 0 | ||
| Issue of equity | € 15,000 | ||
| Number of collaboration contracts | contract | 2 | ||